Multimodal prehabilitation improves serum albumin in humans (before surgery) (38.07 g/l before prehabilitation to 40.67 g/l after prehabilitation).
“Serum albumin levels significantly increased during prehabilitation, rising from 38.07 g/l before prehabilitation to 40.67 g/l after prehabilitation (Z = 3.288, p = 0.001), shown in Fig..”
Human trialbefore surgeryaverage duration of prehabilitation program was 34 days (± 7.99 days)n = 20
GLP-1 receptor agonists are linked with higher serum albumin in humans (versus matched nonusers in maintenance hemodialysis) (mean difference 0.06 (95% CI 0.04-0.08)).
“greater improvements in serum albumin level (3.92 vs 3.86 g/dL, with a mean difference of 0.06 [95% CI, 0.04-0.08])”
Humansversus matched nonusers in maintenance hemodialysis12 months
Dietary care combined with nutritional management increases serum albumin in humans.
“Furthermore, we observed that the levels of albumin, hemoglobin, transferrin, and prealbumin in the DCNM group were significantly higher than those in the conventional group at one, two, three, and six months after care (P < 0.05), indicating a more significant improvement in nutritional status with DCNM care”
Intradialytic nutritional support is linked with higher serum albumin in hemodialysis patients (4.0 [3.7-4.2] g/dL vs. 3.5 [3.2-3.7] g/dL; p < 0.001).
“The group receiving intradialytic nutritional support had significantly higher serum albumin (4.0 [3.7-4.2] g/dL vs. 3.5 [3.2-3.7] g/dL; p < 0.001, respectively)”
Growth hormone increases serum albumin in humans (+5.1 +/- 0.8 vs. 1.6 +/- 1.2 g/dL; P = 0.023).
“Serum albumin level also showed a greater delayed increase in the rhGH group than in the placebo group”
Human trialmedically stable malnourished patients receiving dietary intervention; compared with placebo plus dietary interventionrecombinant human0.09 IU/kg body weight 3 times weekly8 weeksn = 19
Serum albumin is linked with better functional independence in humans (older patients surgically treated for traumatic cervical spine injuries) (OR: 10.7).
“higher serum albumin (OR: 10.7) and lower Charlson Comorbidity Index (OR: 0.46) were associated with better functional outcomes”
European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·
Recurrent hip fracture
↓downin humans1OR 0.413
1 study
Serum albumin is linked with less recurrent hip fracture in humans following surgical treatment of primary osteoporotic hip fractures (OR 0.413, 95% CI 0.194-0.881).
“serum albumin ≥ 35 g·L−1 (OR = 0.413, 95%CI = 0.194-0.881, p = 0.022) were independent protective factors for recurrent hip fractures”
Humansfollowing surgical treatment of primary osteoporotic hip fractures3 yearsn = 376
Serum albumin improves cognitive function prediction accuracy in silico (MSE 5.33 without vs 4.62 with albumin).
“In those aged below 65, the mean squared error (MSE) of the DLM was 5.33 without albumin and 4.62 with albumin, showing a -0.71 improvement with albumin.”
HALP score was not clearly linked with serum albumin in humans (head-to-head comparison for discriminating high multisyndrome burden) (AUC 0.654 vs. 0.677, p = 0.52).
“Neither index discriminated better than serum albumin measured alone (PNI, area under the curve 0.679 vs. 0.677, DeLong p = 0.90; HALP, 0.654 vs. 0.677, p = 0.52).”
Humanshead-to-head comparison for discriminating high multisyndrome burden
Prognostic nutritional index was not clearly linked with serum albumin in humans (head-to-head comparison for discriminating high multisyndrome burden) (AUC 0.679 vs. 0.677, p = 0.90).
“Neither index discriminated better than serum albumin measured alone (PNI, area under the curve 0.679 vs. 0.677, DeLong p = 0.90; HALP, 0.654 vs. 0.677, p = 0.52).”
Humanshead-to-head comparison for discriminating high multisyndrome burden
Age ≥75 years are linked with lower serum albumin in humans (at recurrence).
“At recurrence, serum albumin levels, prognostic nutritional index, Glasgow prognostic score, controlling nutritional status score, and treatment rate were lower in elderly patients.”
Sarcopenia was not clearly linked with serum albumin in highly functional community-dwelling older women (4.18 (SD 0.23) g/dL vs. 4.11 (SD 0.22) g/dL, p=0.235).
“No significant differences in albumin levels were found between women with versus without sarcopenia (mean 4.18 (SD 0.23) g/dL vs. 4.11 (SD 0.22) g/dL, p=0.235).”
Journal of the Formosan Medical Association = Taiwan yi zhi·
Serum albumin predicts mortality in humans (Older Thai adults with positive screening FOBT; per g/dL increase in serum albumin) (aHR 0.43 per g/dL increase, 95% CI 0.32–0.58).
“and serum albumin (aHR 0.43 per g/dL increase, 95% CI 0.32–0.58).”
HumansOlder Thai adults with positive screening FOBT; per g/dL increase in serum albumin5 yearsn = 709
Serum albumin is linked with a lower risk of mortality in humans (ESRD undergoing hemodialysis after hip fracture) (HR 0.19, 95% CI 0.06-0.60 per 1 g/dL increase).
“pre-injury serum albumin level was significantly associated with 1-year mortality in both univariate (hazard ratio [HR] per 1 g/dL increase, 0.15; 95% confidence interval [CI]: 0.05, 0.45) and multivariate analyses (HR per 1 g/dL increase, 0.19; 95% CI: 0.06, 0.60)”
HumansESRD undergoing hemodialysis after hip fracture1 yearn = 66
Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association·
Serum albumin predicts mortality in humans (hazard ratio 0.192, p = 0.004).
“These findings remained significant when albumin was examined as a continuous variable (hazard ratio 0.242, p = 0.001) and even after multivariate adjustment as well (hazard ratio 0.192, p = 0.004).”
Serum albumin is linked with a lower risk of mortality in humans (patients with ANCA-associated vasculitides and kidney involvement (Uppsala cohort)) (HR 0.86, 95% CI 0.79-0.94).
“In the Uppsala cohort (n = 91) serum albumin levels at diagnosis emerged also as an independent risk factor when adjusting for age, kidney function and other inflammatory parameters (HR 0.86, 95% CI 0.79-0.94).”
Humanspatients with ANCA-associated vasculitides and kidney involvement (Uppsala cohort)n = 91
Serum albumin is linked with a higher risk of mortality in humans (weight maintenance) (HR = 6.89, 95%CI = 2.06-23.02).
“Participants with weight maintenance and low serum albumin (HR = 6.89, 95%CI = 2.06-23.02) and those with weight loss and low serum albumin (HR = 19.06, 95%CI = 4.42-82.14) had a higher mortality risk”
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·
Frailty is associated with serum albumin in patients on hemodialysis.
Serum albumin lowers the risk of frailty in silico (β = -0.172 per g/L, 95% CI: -0.336, -0.007, P = 0.041).
“in women, we observed a preventive association between genetically predicted serum albumin and FI (β = -0.172 per g/L; 95% CI: -0.336, -0.007; P = 0.041).”
Serum albumin is associated with cognitive function in humans (adjusted) (adjusted OR: 0.38, p < .001).
“Better cognitive performance was associated with increased body mass index (adjusted OR: 0.74, p-.03), hemoglobin (adjusted OR: 0.91, p-.006), and serum albumin (adjusted OR: 0.38, p < .001).”
Serum albumin is associated with cognitive function in humans (beta = 3.30, p < 0.0001).
“serum albumin levels (assessed by the median serum albumin levels during the study period) were significantly associated with increases in the median MMSE scores (beta = 3.30, p < 0.0001).”
Serum albumin is associated with cognitive function in humans (compared with lowest quartile group) (from 23.22 in lowest quartile to 25.07 in highest quartile).
“adjusted MMSE score increased from 23.22 in the lowest quartile group to 25.07 in the highest quartile group (P for linear trend <0.001)”
Serum albumin is linked with a lower risk of in-hospital mortality in humans (multivariable logistic regression) (aOR 0.35 (95% CI 0.16-0.70), P = 0.004).
“a higher serum albumin level was independently associated with lower in-hospital mortality (adjusted odds ratio [aOR], 0.35; 95% confidence interval [CI], 0.16-0.70; P = 0.004)”
Serum albumin is associated with in-hospital mortality in humans (gastric cancer surgery; preoperative albumin ≤2.95 g/dl) (OR 0.15, 95% CI 0.04–0.93; AUC 0.74).
“In-hospital mortality (6/263 patients) was significantly associated with preoperative albumin ≤2.95 g/dl”
Humansgastric cancer surgery; preoperative albumin ≤2.95 g/dln = 263
Serum albumin is linked with a lower risk of height loss in humans (OR 0.92 (0.86, 0.98)).
“the adjusted odd ratio (OR) and 95% confidence interval (CI) for height loss per 1 standard deviation of albumin (0.2 g/dL for both men and women) were 0.92 (0.86, 0.98) in men”
Humansper 1 standard deviation of albumin (0.2 g/dL)males
Serum albumin is associated with cognitive impairment in humans.
“The cognitive impairment in elderly dialysis patients was significantly associated with age, dialysis vintage, and levels of serum albumin and hemoglobin.”
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·
Serum albumin is linked with a lower risk of cognitive impairment in humans (highest quartile vs lowest quartile) (OR 0.43, 95% CI 0.27-0.69).
“OR (95%CI) for the lower, higher and highest quartile groups was 0.64(0.45-0.91), 0.60(0.40-0.89) and 0.43(0.27-0.69), respectively, compared with the lowest quartile group”
Loss of kidney filtering units under metabolic and cardiovascular stress led to wasting independent of calorie intake, with muscle loss and frailty-like features.Loss of kidney filtering units under metabolic and cardiovascular stress led to wasting independent of calorie intake, with muscle loss and frailty-like features.
An observational analysis of US survey data from 2011–2018 found links to sarcopenia and sarcopenia with obesity, with stronger associations in older adults.An observational analysis of US survey data from 2011–2018 found links to sarcopenia and sarcopenia with obesity, with stronger associations in older adults.